Researchers at LSU Health New Orleans Neuroscience Center of Excellence and colleagues have discovered a new class of pipeline drugs to relieve pain and reduce fever without the danger of addiction or ...
New research published online in The FASEB Journal suggests that a novel therapeutic target called LPCAT2 may prove effective against pain that is not receptive to the current treatments. This study ...
Nektar Therapeutics announced positive results from the SUMMIT-07 Phase 3 study of NKTR-181, a first-in-class opioid analgesic for the treatment of moderate to severe chronic pain. Nektar Therapeutics ...
Opioids and stimulants are distinct drug classes: opioids are pain relievers that depress the nervous system, while stimulants increase alertness and energy levels. Opioids act as potent pain ...
SHANGHAI, June 19, 2018 /PRNewswire/ -- June 19, 2018, Luye Pharma Group announced that clinical applications of the company's new compound candidate, extended release tablets (''LY03012''), a China ...
SAN FRANCISCO--(BUSINESS WIRE)--Concentric Analgesics, Inc., a clinical-stage biopharmaceutical company focused on developing and commercializing novel, non-opioid pain therapeutics, today announced ...
SAN FRANCISCO--(BUSINESS WIRE)--Concentric Analgesics, Inc., a clinical-stage biopharmaceutical company focused on developing and commercializing novel, non-opioid pain therapeutics, today announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback